Loading...
BGM Group Ltd.
BGM•NASDAQ
Healthcare
Drug Manufacturers - Specialty & Generic
$10.45
$-0.50(-4.57%)
BGM Group Ltd. (BGM) Financial Performance & Income Statement Overview
Review BGM Group Ltd.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
-45.99%
↓ 45.99%
Operating Income Growth
78.40%
↑ 78.40%
Net Income Growth
81.46%
↑ 81.46%
Operating Cash Flow Growth
74.32%
↑ 74.32%
Operating Margin
-2.25%
↓ 2.25%
Gross Margin
16.39%
↑ 16.39%
Net Profit Margin
-5.75%
↓ 5.75%
ROE
-3.37%
↓ 3.37%
ROIC
-1.27%
↓ 1.27%
BGM Group Ltd. (BGM) Income Statement & Financial Overview
Review BGM Group Ltd.'s (BGM) income statement with detailed quarterly and annual figures.
| Metric | Q2 2024 |
|---|---|
| Revenue | $12.56M |
| Cost of Revenue | $11.15M |
| Gross Profit | $1.41M |
| Gross Profit Ratio | $0.11 |
| R&D Expenses | $0.00 |
| SG&A Expenses | $2.09M |
| Operating Expenses | $2.09M |
| Total Costs & Expenses | $13.24M |
| Interest Income | $57782.00 |
| Interest Expense | $0.00 |
| Depreciation & Amortization | $0.00 |
| EBITDA | -$679088.00 |
| EBITDA Ratio | -$0.05 |
| Operating Income | -$679088.00 |
| Operating Income Ratio | -$0.05 |
| Other Income/Expenses (Net) | $1.02M |
| Income Before Tax | $340716.00 |
| Income Before Tax Ratio | $0.03 |
| Income Tax Expense | $11936.00 |
| Net Income | $328780.00 |
| Net Income Ratio | $0.03 |
| EPS | $0.05 |
| Diluted EPS | $0.05 |
| Weighted Avg Shares Outstanding | $7.23M |
| Weighted Avg Shares Outstanding (Diluted) | $7.23M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan